uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 28, 2008

Seizure of Xiadafil VIP Tablets After Company Refuses Recall

On July 24, 2008, the FDA announced that U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at